The life sciences have made a strong showing in the Greater Philadelphia region this year, as local companies raked in a record $777 million in venture capital in the first half of 2021 alone. Add it to the tally: A University of Pennsylvania spinout has raised a $50 million Series A to advance its gene editing technology.
April 24, 2022
What do the numbers so far say about 2022? Philadelphia saw a shocking amount of venture capital flowing into the region in VC deals in 2021 — by far the...
April 22, 2022
It’s not solving a new problem, but Oncora Medical’s CEO is finding that the company’s product has an unfortunate timeliness amid the pandemic. Read the full article here.